Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market.

AZ promises to deliver 400m doses of COVID-19 vaccine to Eur...

AstraZeneca has followed through on its pledge to provide its COVID-19 vaccine at cost during the pandemic, saying it has agreed to supply 400m doses to the European Inclusive

European VCs ‘actively seeking new healthcare investments’

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne

ECJ backs UK regulator’s ‘pay-for-delay’ fine levied on GSK

Shaping the patient-centric evolution of HTA in Europe

Patient engagement is one of the most important drivers for improving healthcare delivery but, as Krystallia Pantiri explains, approaches by European health technology assessment (HTA) bodi

Transforming oncology with a pan-European approach to data s...

Between genomic data, electronic health records and digital health tools, we have all the information we need to transform the fortunes of people living with cancer – but how do we ensure i